Stern Martin, Bertrand Dominique Pougheon, Bignamini Elisabetta, Corey Mary, Dembski Birgit, Goss Christopher H, Pressler Tanja, Rault Gilles, Viviani Laura, Elborn J Stuart, Castellani Carlo
University Children's Hospital, Tübingen, Germany.
French CF QIP, Paris, France.
J Cyst Fibros. 2014 May;13 Suppl 1:S43-59. doi: 10.1016/j.jcf.2014.03.011.
Since the earliest days of cystic fibrosis (CF) treatment, patient data have been recorded and reviewed in order to identify the factors that lead to more favourable outcomes. Large data repositories, such as the US Cystic Fibrosis Registry, which was established in the 1960s, enabled successful treatments and patient outcomes to be recognized and improvement programmes to be implemented in specialist CF centres. Over the past decades, the greater volumes of data becoming available through Centre databases and patient registries led to the possibility of making comparisons between different therapies, approaches to care and indeed data recording. The quality of care for individuals with CF has become a focus at several levels: patient, centre, regional, national and international. This paper reviews the quality management and improvement issues at each of these levels with particular reference to indicators of health, the role of CF Centres, regional networks, national health policy, and international data registration and comparisons.
自囊性纤维化(CF)治疗开展之初,就开始记录和审查患者数据,以确定能带来更有利治疗结果的因素。大型数据库,如20世纪60年代建立的美国囊性纤维化登记处,使成功的治疗方法和患者治疗结果得以被认可,并促使在专业CF中心实施改进计划。在过去几十年里,通过中心数据库和患者登记处可获得的大量数据使得比较不同治疗方法、护理方式以及数据记录成为可能。CF患者的护理质量在患者、中心、地区、国家和国际等多个层面都成为了关注焦点。本文回顾了这些层面各自的质量管理和改进问题,特别提及健康指标、CF中心的作用、地区网络、国家卫生政策以及国际数据登记和比较。